What We're Reading: Page 153
Industry reads hand-picked by our editors
Aug 19, 2021
-
STAT
‘Remember her as the badass she was’: ALS patient who died should force Biogen, others to anticipate expanded access issues
-
The Wall Street Journal
As Covid-19 Boosters Loom, Pfizer and Moderna Expected to See Billions More in Sales
-
Science
COVID-19 vaccines may trigger superimmunity in people who had SARS long ago
-
Reuters
China's mRNA vaccine technology firm Abogen raises over $700 million
Aug 18, 2021
-
Forbes
Covid’s Forgotten Hero: The Untold Story Of The Scientist Whose Breakthrough Made The Vaccines Possible
-
STAT
Sesen Bio drug trial marked by misconduct, other issues, documents show
-
The New York Times
Sacklers Threaten to Pull Out of Opioid Settlement Without Broad Legal Immunity
-
FiercePharma
5 years after Pfizer buyout, SEC charges Medivation's former deal-making lead with insider trading
Aug 17, 2021
-
Bloomberg
Antibody Cocktails Take Off as Delta Surges
-
The New York Times
This Breast Cancer Gene Is Less Well Known, but Nearly as Dangerous
-
Associated Press
Rich nations dip into COVAX supply while poor wait for shots
-
Endpoints News
Dueling 7-figure ad campaigns set sights on a big drug price negotiation bill coming soon
Aug 16, 2021
-
Associated Press
Former FDA chief on the case for a more independent agency
-
The New York Times
U.S. Preparing Plan to Offer Vaccine Boosters, Perhaps By Fall
-
Endpoints News
Prosecutors secure guilty plea in $110M biotech scam at Vermont ski resort
-
Evaluate Vantage
Travere lines up another shot at speedy sparsentan approval
Aug 13, 2021
-
The New York Times
F.D.A. Approves GHB, a 'Date Rape' Drug, for Rare Sleeping Disorder
-
STAT
Ellis Unger, an outspoken FDA veteran, resigns
-
The Atlantic
Vaccine Analogies Are Failing Us
-
Bloomberg
The Tesla-fication of Moderna Is a Rich Tale
Aug 12, 2021
-
CNN
Biden struggles to find a permanent FDA chief as agency nears approval of Covid-19 vaccine
-
Science
'Landmark' study finds artificial antibodies can protect against malaria
-
STAT
Scientist Aubrey de Grey put on leave over sexual harassment allegations
-
Evaluate Vantage
Fate looks to justify its $9bn valuation
Aug 11, 2021
-
Endpoints News
'The consummate mentor': Bill Clinton, Jim Wilson and others reflect on Tachi Yamada's life and legacy
-
C&EN
Big ambitions for India's contract research firms
-
Reuters
Inovio focused on launching global COVID-19 vaccine trial next month - CEO
-
FiercePharma
How did big pharma perform in China in H2?
Previous
